[1] Pace B,Lynm C.Benefits of physical activity for the heart[J].JAMA,2001,285(11):1536.
[2] WHO.The global burden of disease [R].Geneva,2008.
[3] 张文范.我国人口老龄化与战略性选择[J].城市规划,2002,26(2):68-72.
[4] 陈红卫.通心络胶囊治疗冠心病心绞痛疗效观察[J].医学理论与实践,2002,15(10):1122-1123.
[5] 冯 平,曾 海,李 萍.通心络胶囊治疗冠心病心绞痛疗效观察[J].中国中医急症,2003,12(6):534.
[6] 郭晓梅.通心络胶囊治疗冠心病60例临床研究[J].疑难病杂志,2008,7(3):161-162.
[7] 蒋义生.通心络胶囊治疗冠心病稳定型心绞痛的疗效观察[J].临床合理用药杂志,2010,3(20):66-67.
[8] 金筠菁,何 彬.通心络胶囊治疗老年冠心病心绞痛临床疗效观察[J].中国民康医学,2003,15(9):526-528.
[9] 李启云.通心络胶囊治疗冠心病、心绞痛合并高脂血症60例[J].菏泽医学专科学校学报,2004,16(2):19-21.
[10] 李亚萍.通心络胶囊治疗冠心病心绞痛的疗效观察[J].中国校医,2003,17(6):486-488.
[11] 骆小敏.通心络胶囊治疗冠心病心绞痛34例临床观察[J].中国医药导报,2010,7(32):56-57.
[12] 齐 炜,齐 宏.通心络胶囊治疗冠心病心绞痛64例临床观察[J].中国民族民间医药,2010,19(24):127-128.
[13] 王富收.不稳定型心绞痛临床治疗分析[J].中国实用医药,2011,6(21):94-95.
[14] 张连祥,李春昕.通心络胶囊治疗冠心病心绞痛90例临床观察[J].医学研究与教育,2009,26(2):62-63.
[15] Moher D,Pham B,Jones A,et al.Does quality of reports of randomised trials affect estimates of intervention efficacy reported in Meta-analyses[J].Lancet,1998.352(9128):609-613.
[16] Kjaergard LL,Villumsen J,Gluud C.Reported methodologic quality and discrepancies between large and small randomized trials in Meta-analyses[J].Ann Intern Med,2001,135(11):982-989.
[17] 谢景涛.中医药走向世界的产品策略[J].经济研究导刊,2011,(14):173-174.
[18] 丁 炜,魏睦新.中医药走向世界,疗效才是硬道理[J].中国中医药咨讯,2010,2(36):74.
[19] Juni P,Witschi A,Bloch R,et al.The hazards of scoring the quality of clinical trials for Meta-analysis[J].JAMA,1999,282(11):1054-1060.